New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
20:25 EDTWMT, WMT, PRGO, PRGO, KSS, KSS, AAP, AAP, HMHC, HMHC, RRGB, RRGB, BGG, BGGNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Wal-Mart (WMT), consensus $1.21; Perrigo (PRGO), consensus $1.55; Kohl's (KSS), consensus $1.07; Advance Auto Parts (AAP), consensus $2.01; Houghton Mifflin (HMHC), consensus 14c; Red Robin (RRGB), consensus 90c; and Briggs & Stratton (BGG), consensus 36c.
News For WMT;PRGO;KSS;AAP;HMHC;RRGB;BGG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 17, 2015
07:04 EDTWMTWal-Mart sees Q4 EPS $1.40-$1.55, consensus $1.43
Subscribe for More Information
07:03 EDTWMTWal-Mart reports Q3 continuing ops EPS $1.03, consensus 98c
Reports Q3 revenue $117.41B, consensus $117.79B. Q3 diluted EPS from continuing operations was $1.03, benefited by approximately 4c from an adjustment for certain leases. Currency negatively impacted EPS by 4c. On a constant currency basis1, total revenue was $122.4 billion, an increase of 2.8%.
06:39 EDTWMTWal-Mart Asia CEO: China to drive over half of sector growth, CNBC says
Subscribe for More Information
06:27 EDTWMTWal-Mart may see worst y/y decline since 1973, WSJ says
Wal-Mart's stock has slumped roughly 40% since reaching over $90 in January, setting the company up for its worst year over year decline since 1973, Steven Russolillo of the Wall Street Journal's Ahead of the Tape reports. There is not much reason to believe that the retailer's shares will rebound ahead of Tuesday's quarterly report, Russolillo says. Deflationary concerns and the growing e-commerce market represent two structural issues hindering Wal-Mart's ability to stage swift turnaround, the report says. Reference Link
November 16, 2015
16:53 EDTPRGO, HMHCPaulson reduced stake in Valeant
Paulson & Co. gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Perrigo (PRGO), CIT Group (CIT), Precision Castparts (PCP), Cameron (CAM), and Altera (ALTR). INCREASED STAKES: Teva (TEVA), Post Holdings (POST), Starwood Hotels (HOT), LivaNova (LIVN), and Synergy Pharmaceuticals (SGYP). DECREASED STAKES: Valeant (VRX), Shire (SHPG), Whiting Petroleum (WLL), Computer Sciences (CSC), and Oasis Petroleum (OAS). LIQUIDATED STAKES: Houghton Mifflin Harcourt (HMHC), Broadcom (BRCM), and Sprint (S).
16:23 EDTWMTOn The Fly: Top stock stories for Monday
Stock futures were pointing to a higher open early this morning, showing resiliency in the wake of Friday's terrorist attacks in France and the nation's millitary retaliation against ISIS this weekend. However, the futures weakened following the release of manufacturing data from the N.Y. region, leading to a slightly lower open for the broader market. The averages pared their losses and searched for direction in early trading, but by early afternoon the bulls took control and sent the indexes on an uptrend throughout the afternoon. The major averages each notched gains of more than 1% and recaptured much of what they'd lost on Friday. ECONOMIC EVENTS: In the U.S., the Empire State index, which measures manufacturing in the N.Y. region, edged up to -10.74 in November, up from last month's -11.4, but below expectations for a -6.5 reading. In Asia, Japan's gross domestic product declined 0.8% in the third quarter, missing expectations for a 0.2% decrease and taking the nation's economy back into recession. COMPANY NEWS: Starwood Hotels & Resorts (HOT) found a buyer, but not the one that recent reports had been foreshadowing. Starwood and Marriott (MAR) announced a deal under which the companies will combine in a cash and stock transaction valued at $12.2B to create the world's largest hotel company. Starwood, which had been linked in media reports to a number of other potential buyers in the past, including Hyatt (H) most recently, fell 3.6% to $72.27 following the deal announcement, while Hyatt rose 3.4% and Marriott added 1.35%. MAJOR MOVERS: Among the notable gainers was CONSOL Energy (CNX), which advanced 56c, or 7.57%, to $7.96 after Greenlight Capital's David Einhorn reiterated the stock as his "best idea" at Monday's Robin Hood Investors Conference. Also higher was Wal-Mart (WMT), gaining $1.44, or 2.55%, to $57.87 ahead of its third quarter earnings report Tuesday morning, which comes after largely disappointing reports from other major retailers. Among the noteworthy losers was Clovis Oncology (CLVS), which crashed $69.19, or 69.6%, to $30.24 after new data showed the number of patients testing its cancer drug candidate rociletinib with an unconfirmed response who converted to a confirmed response was lower than expected. The company also noted that the FDA requested additional information related to the treatment's confirmed response rates. Also lower was Dillard's (DDS), which lost $4.97, or 6.41%, to $72.54 after reporting lower than expected Q3 results, the latest in a series of disappointments for the sector. Additionally, SunEdison (SUNE) fell 38c, or 7.61%, to $4.55 after quarterly filings revealed that at least two prominent hedge funds exited or trimmed their stakes in the company. INDEXES: The Dow rose 237.77, or 1.38%, to 17,483.01, the Nasdaq gained 56.73, or 1.15%, to 4,984.62, and the S&P 500 advanced 30.15, or 1.49%, to 2,053.19.
15:02 EDTWMTNotable companies reporting before tomorrow's open
Subscribe for More Information
14:08 EDTWMTWal-Mart technical comments ahead of results
The shares are at multi-year lows and in a downtrend heading into earnings news. If there was a bullish surprise, the first important resistance level would be at the 10-week moving average at $60.58. The 10-week is a good proxy for a downtrend resistance line for the current longer-term bearish price channel. Resistance above the top of the channel would be at $61.23. If the news continues to be negative, the channel low at $55.46 would be a first major test of support. Price at that level would mark a fresh 52-week low. Additional support levels to watch as potential downside objectives would be at $53.55 and then at $51.79.
14:00 EDTWMTWal-Mart November 57 straddle priced for 3.5% movement into Q3
Subscribe for More Information
11:42 EDTWMTWal-Mart volatility increases into Q3 and outlook
Subscribe for More Information
11:35 EDTKSSDillard's sinks to 52-week low after joining chorus of 'disappointed' retailers
Shares of Dillard's (DDS), a retailer of fashion apparel, cosmetics and home furnishing, are falling to their worst level in a year after the company became the latest in its industry to report lower than expected third quarter results. WHAT'S NEW: This morning, Dillard's reported Q3 earnings per share of $1.19 and revenue of $1.435B, narrowly missing analysts' consensus estimates of $1.20 and $1.49B, respectively. Same-store sales for the quarter fell 4%. Total merchandise sales decreased 3% for the 13-week period ended October 31. Weaker performing categories were men's apparel and accessories and ladies' accessories and lingerie with notable weakness in home and furniture the company explained. Dillard's Chief Executive Officer, William T. Dillard, II, stated, "We are disappointed with our third quarter sales performance and in the resulting decline in profit. Share buyback remained a high priority, and we repurchased $175 million of stock under our share repurchase program." WHAT'S NOTABLE: Gross margin from retail operations improved 11 basis points of sales for the 13 weeks ended October 31 compared to the prior year third quarter. Consolidated gross margin for the 13 weeks ended October 31 declined 30 basis points of sales compared to the prior year third quarter. The disparity between retail and consolidated gross margin performance is attributable to increased revenue at CDI, which is a substantially lower margin business. Inventory increased 6% at October 31 compared to November 1, 2014. For FY15, the company expects capital expenditures of $150M. PRICE ACTION: In late morning trading, Dillard's fell $5.81, or 7.5%, to $71.79 on more than three times its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week low of $68.05. Including today's pull back, the shares have lost about 36% over the past 12 months. OTHERS TO WATCH: Other apparel, cosmetics and home furnishing retailers include Macy's (M), Kohl's (KSS), JC Penny (JCP), Sears (SHLD) and Nordstrom (JWN).
11:15 EDTWMTEarnings Watch: Analysts largely downbeat on Wal-Mart after annual meeting
Wal-Mart Stores (WMT) is scheduled to report third quarter earnings before the market open on Tuesday, November 17, with a conference call scheduled for 7:00 am ET. Wal-Mart, a member of the Dow Jones Industrial Average, operates retail stores in various formats under 69 different banners in 27 countries with its "everyday low price" philosophy. EXPECTATIONS: Analysts are looking for earnings per share of 98c on revenue of $117.79B, according to First Call. The consensus range for EPS is $1.07-$1.15 on revenue of $114.86B-$119.57B. In its last earnings report, Wal-Mart forecast Q3 EPS of 93c-$1.05 with Q3 U.S. same store sales projected to grow 2%-3%. LAST QUARTER: Wal-Mart reported second quarter EPS of $1.08, missing analysts' estimate of $1.12, on revenue of $120.2B, beating analysts' estimate of $119.72B. The company said currency negatively impacted Q2 EPS by approximately 4c. Comp sales at Walmart U.S. increased 1.5%, driven by traffic of 1.3%, and Neighborhood Market comps increased approximately 7.3%. Global e-commerce sales for Q2 increased about 16%, the company said. Looking ahead, Wal-Mart cut its outlook for fiscal year 2016 EPS to $4.40-$4.70 from $4.70-$5.05 against estimates at that time for $4.77. Chief Financial officer Charles Holley said operating profit would be pressured for the remainder of the year, due to in store associate wages and additional hours, as well as headwinds from pharmacy reimbursements and ongoing shrink. The company said that the impact from investments in wages, training and additional hours in its stores and clubs will be approximately 24c, including approximately 8c in Q3. Additionally, the company said that along with pharmacy headwinds, higher than expected ongoing shrink in Walmart U.S. will impact full year EPS by around 11c, including about 3c in Q3. Further, the FY16 currency exchange rate impact is expected to be approximately 15c, up 2c from last quarter's revised guidance of 13c. NEWS: At its annual meeting on October 14, Wal-Mart forecast net sales growth of approximately 3% for FY16 excluding the impact of currency exchange fluctuations. The company forecast net sales growth of 3%-4% annually over the next three years, which will add about $45B-$60B in sales. Looking to fiscal year 2017, Wal-Mart forecast EPS down 6%-12% vs. FY16. Wal-Mart also said that the strong dollar is expected to reduce the company's FY15 revenue by $15B, Reuters said. Wal-Mart's board authorized a new $20B share repurchase program and said it expects operating income to bottom out in FY17. During the quarter, Reuters reported that Wal-Mart filed an application with the Federal Aviation Administration to test drones for home delivery, curbside pickup and warehouse inventory checks. The Wall Street Journal said Wal-Mart is slimming down its number of items in an attempt to bolster sales figures, yet the reduction has created tensions with suppliers. STREET RESEARCH: Credit Suisse, Stephens and BofA Merrill Lynch all downgraded Wal-Mart after the retailer's annual meeting based on guidance for declining earnings in FY17 and a lack of earnings growth until FY19. Baird, UBS and Jefferies all cut their price targets on Wal-Mart following the annual meeting. JPMorgan analyst Christopher Horvers said the "depth and degree" of the financial pressures addressed at the annual meeting were "much greater than anticipated." Ahead of the Q3 earnings report, Baird reiterated its Outperform rating and $70 price target and said Wal-Mart shares appear to hold some value for patient investors. Wal-Mart was upgraded to Buy from Neutral at Northcoast on November 13. PRICE ACTION: Wal-Mart shares are down over 21% over the last three months, but are up about 1% to $57.07 in late morning trading ahead of Tuesday's earnings report.
10:25 EDTKSS, PRGOOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTPRGOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alliant Energy (LNT) upgraded to Outperform from Market Perform at Wells Fargo... AmerisourceBergen (ABC) upgraded to Equal Weight from Underweight at Morgan Stanley... Amphenol (APH) upgraded to Buy from Neutral at Goldman... CA Technologies (CA) upgraded to Neutral from Sell at Citi... Cempra (CEMP) upgraded to Overweight from Equal Weight at Morgan Stanley... Edgewell Personal Care (EPC) upgraded to Neutral from Sell at Goldman... Eli Lilly (LLY) upgraded on improved growth outlook at BMO Capital... MiMedx (MDXG) upgraded to Strong Buy from Buy at Needham... NVIDIA (NVDA) upgraded to Buy from Hold at Canaccord... New York REIT (NYRT) upgraded to Buy from Hold at Evercore ISI... Oracle (ORCL) upgraded to Conviction Buy from Buy at Goldman... Perrigo (PRGO) upgraded to Buy from Neutral at UBS... Semtech (SMTC) upgraded to Buy from Neutral at B. Riley... Tullow Oil (TUWOY) upgraded to Buy from Neutral at UBS... Wabtec (WAB) upgraded to Outperform on valuatoin at Raymond James.
09:19 EDTPRGOOn The Fly: Pre-market Movers
HIGHER: Nexvet Biopharma (NVET), up 16.8% after NV-01 study meets primary endpoint... Protalix BioTherapeutics (PLX), up 4.8% after announcing that it will conduct a Phase III clinical trial for PRX-102... Array Biopharma (ARRY), up 4.3% after announcing a commercialization collaboration with Pierre Fabre... Perrigo (PRGO), up 2.1% after being upgraded to Buy from Neutral at UBS. DOWN AFTER EARNINGS: Dillard's (DDS), down 11.7% after reporting quarterly results. ALSO LOWER: Clovis Oncology (CLVS), down 71.3% after the FDA requested additional clinical data for rociletinib... KaloBios Pharmaceuticals (KBIO), down 48.9% after announcing that it will wind down its operations... Starwood Hotels (HOT), down 6.3% after announcing that Marriott (MAR) will acquire the company... Marriott is down 2.4%... Five Below (FIVE), down 3.1% after being downgraded to Hold from Buy at Deutsche Bank.
08:36 EDTWMTWal-Mart holds value for patient long-term investors, says Baird
Subscribe for More Information
07:40 EDTWMTBuffett says lower stakes in Goldman, Wal-Mart doesn't reflect lower confidence
Subscribe for More Information
07:36 EDTWMTBerkshire Hathaway discloses new AT&T stake in quarterly update
Berkshire Hathaway gave a quarterly update on its stakes in a filing this morning. NEW STAKES: AT&T (T), Kraft Heinz (KHC), Liberty Lilac Group (LILA). INCREASED STAKES: Phillips 66 (PSX), Charter (CHTR), Liberty Media (LMCK), Suncor (SU), General Motors (GM). DECREASED STAKES: Goldman Sachs (GS), Wal-Mart (WMT), Deere (DE), Chicago Bridge & Iron (CBI), WABCO (WBC). LIQUIDATED STAKES: Viacom (VIAB).
07:16 EDTPRGOHayman Capital gives quarterly update on stakes
NEW STAKES: Impax (IPXL), CF Industries (CF), GW Pharmaceuticals (GWPH), ProNAi Therapeutics (DNAI). INCREASED STAKES: BioMarin (BMRN), NMI Holdings (NMIH), Vertex (VRTX), Endo (ENDP). DECREASED STAKES: Mylan (MYL). LIQUIDATED STAKES: Perrigo (PRGO), Oasis Petroleum (OAS), Whiting Petroleum (WLL), Newfield Exploration (NFX), SM Energy (SM).
05:53 EDTPRGOPerrigo upgraded to Buy from Neutral at UBS
UBS analyst Marc Goodman upgraded Perrigo (PRGO) to Buy saying investor focus should soon turn back to fundamentals following Mylan's (MYL) failed takeover attempt. Perrigo management can deliver mid-single digit revenue growth that drives mid-teens earnings growth over the next five years, Goodman tells investors in a research note. His price target for the stock remains $200. Perrigo closed Friday down $9.65 to $146.90.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use